Windlas Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	8,683	7,599	6,310	5,131	4,659	4,276
Revenue Growth (YoY)	19.20%	20.43%	22.97%	10.12%	8.96%	30.03%
Cost of Revenue	5,383	4,748	4,004	3,296	3,079	2,791
Gross Profit	3,300	2,851	2,305	1,835	1,581	1,485
Selling, General & Admin	1,463	1,265	927.74	736.88	656.86	596.43
Other Operating Expenses	783.45	640.8	595.94	495.85	399.53	324.41
Operating Expenses	2,557	2,186	1,658	1,356	1,178	1,050
Operating Income	742.98	664.94	647.28	478.7	402.76	434.14
Interest Expense	-46.78	-43.82	-11.05	-7.88	-14.17	-12.9
Interest & Investment Income	15.45	15.45	19.69	34.9	42.85	19.21
Earnings From Equity Investments	-	-	-	-	-	-1.73
Currency Exchange Gain (Loss)	4.88	4.88	3.23	3.82	4.77	1.03
Other Non Operating Income (Expenses)	8.98	5.25	3.49	4.35	0.77	1.98
EBT Excluding Unusual Items	725.51	646.7	662.64	513.89	436.98	441.73
Impairment of Goodwill	-	-	-	-	-	-272.64
Gain (Loss) on Sale of Investments	150.79	150.79	108.21	47.82	18.57	62.22
Gain (Loss) on Sale of Assets	0.09	0.09	0.06	8.76	0.1	0.09
Asset Writedown	-	-	-	-0.08	-	-14
Pretax Income	876.39	797.58	770.91	570.39	455.65	217.4
Income Tax Expense	208.92	187.64	189.04	144.13	74.76	61.7
Earnings From Continuing Operations	667.47	609.94	581.87	426.26	380.89	155.7
Minority Interest in Earnings	-	-	-	-	-	2.62
Net Income	667.47	609.94	581.87	426.26	380.89	158.32
Net Income to Common	667.47	609.94	581.87	426.26	380.89	158.32
Net Income Growth	8.17%	4.82%	36.51%	11.91%	140.58%	-2.35%
Shares Outstanding (Basic)	21	21	21	22	20	18
Shares Outstanding (Diluted)	21	21	21	22	20	18
Shares Change (YoY)	0.73%	1.22%	-3.53%	5.56%	12.58%	-
EPS (Basic)	31.79	29.19	27.97	19.70	18.58	8.70
EPS (Diluted)	31.44	28.87	27.88	19.70	18.58	8.70
EPS Growth	7.38%	3.55%	41.52%	6.03%	113.68%	-2.30%
Free Cash Flow	-	159.93	712.76	-99.25	-56.74	56.07
Free Cash Flow Per Share	-	7.57	34.15	-4.59	-2.77	3.08
Dividend Per Share	-	5.800	5.500	4.000	3.500	-
Dividend Growth	-	5.46%	37.50%	14.29%	-	-
Gross Margin	38.00%	37.52%	36.54%	35.77%	33.92%	34.72%
Operating Margin	8.56%	8.75%	10.26%	9.33%	8.64%	10.15%
Profit Margin	7.69%	8.03%	9.22%	8.31%	8.18%	3.70%
Free Cash Flow Margin	-	2.10%	11.30%	-1.93%	-1.22%	1.31%
EBITDA	1,085	909.63	762.1	586.88	515.48	552.26
EBITDA Margin	12.50%	11.97%	12.08%	11.44%	11.06%	12.91%
D&A For EBITDA	342.09	244.69	114.82	108.18	112.72	118.12
EBIT	742.98	664.94	647.28	478.7	402.76	434.14
EBIT Margin	8.56%	8.75%	10.26%	9.33%	8.64%	10.15%
Effective Tax Rate	23.84%	23.53%	24.52%	25.27%	16.41%	28.38%
Revenue as Reported	8,867	7,779	6,444	5,230	4,726	4,307
Advertising Expenses	-	27.87	48.32	29.75	18.4	12.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.